Current Trends in Genitourinary Malignancies
The Westin Pasadena
Pasadena, CA
October 31, 2009
David I. Quinn, MBBS, PhD, FRACP
Associate Professor of Medicine
Medical Director, Norris Cancer Hospital and Clinics
Co-Leader, Genitourinary Cancer Program
Keck School of Medicine of the University of Southern California
Los Angeles, CA
Monish Aron, MD
Professor of Clinical Urology
Department of Urology
Co-Director, Robotic Surgery & Advanced Laparoscopy
USC Institute of Urology
Keck School of Medicine of the University of Southern California
Los Angeles, CA
Tanya B. Dorff, MD
Assistant Professor of Medicine
Genitourinary Oncology
USC/Norris Comprehensive Cancer Center
Keck School of Medicine of the University of Southern California
Los Angeles, CA
Robert A. Figlin, MD, FACP
Arthur and Rosalie Kaplan Professor of Medical Oncology
Chairman, Department of Medical Oncology & Therapeutics Research
City of Hope National Medical Center/Beckman Research Institute
City of Hope Comprehensive Cancer Center
Duarte, CA
Matthew D. Galsky, MD
Director, Phase I Clinical Trials Program
Comprehensive Cancer Centers of Nevada
Las Vegas, NV
Mitchell Gross, MD, PhD
Research Director
USC Westside Prostate Cancer Center and USC Center for Applied Molecular Medicine
Associate Professor of Medicine
Keck School of Medicine of the University of Southern California
Los Angeles, CA
Ronald B. Natale, MD
Medical Oncologist
Cedars-Sinai Comprehensive Cancer Center
Director and Senior Research Advisor
National Lung Cancer Research Program
Aptium Oncology, Inc.
Los Angeles, CA
Charles J. Ryan, MD
Associate Clinical Professor of Medicine
University of California, San Francisco Comprehensive Cancer Center
San Francisco, CA
Nicholas J. Vogelzang, MD
Chair and Medical Director, Developmental Therapeutics
Co-Chair, GU Committee
US Oncology Research
Comprehensive Cancer Centers of Nevada
Las Vegas, NV